Financhill
Back

Lantern Pharma Stock Predictions

Lantern Pharma Stock Forecast

  • Is Lantern Pharma Stock Undervalued?
    The current Lantern Pharma [LTRN] share price is $3.38. The Score for LTRN is 33, which is 34% below its historic median score of 50, and infers higher risk than normal.
  • LTRN is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.

Will Lantern Pharma Stock Go Up Next Year?

Data Unavailable

Lantern Pharma Stock Rating

Data Unavailable

Lantern Pharma Stock Price History

Is LTRN stock going to rise?

  • Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and LTRN is experiencing slight buying pressure.

Stock Information

Stock Info

Exchange:
NASDAQ
Country:
United States
Industry:
Biotechnology
Sector:
Health Care
Type:
stock
Website:
lanternpharma.com

52-Week Data

52-Week High:
6.12
52-Week Low:
2.55

Prediction Charts

Market Cap:
36.5M
Price in USD:
3.38
Volume:
17.6K
Beta:
1.57

Technical Analysis

SMA50:
3.43
SMA100:
3.82
SMA200:
3.71
52-Wk Change:
-39.53%

Stock Predictions

  • Is Lantern Pharma stock public?
    Yes, Lantern Pharma is a publicly traded company.
  • What is the Lantern Pharma stock quote today?
    The Lantern Pharma stock price is 3.38 USD today.
  • How to buy Lantern Pharma stock online?
    You can buy Lantern Pharma shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.

14-Day Historical Data

Date Opening Closing Minimum Maximum
May-22 3.29 3.35 3.44 3.24
May-23 3.30 3.29 3.42 3.19
May-27 3.27 2.90 3.27 2.87
May-28 2.89 2.87 2.98 2.85
May-29 2.90 3.13 3.23 2.90
May-30 3.10 3.05 3.15 2.97
Jun-2 3.08 3.19 3.22 3.05
Jun-3 3.24 3.22 3.28 3.19
Jun-4 3.22 3.34 3.35 3.20
Jun-5 3.33 3.43 3.48 3.28
Jun-6 3.28 3.32 3.43 3.25
Jun-9 3.32 3.37 3.37 3.27
Jun-10 3.40 3.37 3.41 3.30
Jun-11 3.41 3.38 3.42 3.27

Lantern Pharma Earnings

Data Unavailable

Lantern Pharma Forecast Revenue Growth

Data Unavailable

  • Analysts estimate an earnings increase this quarter of $0.01 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.09 per share, and an increase next year of $0.28 per share.

* Lantern Pharma stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.